Begin the process.
Advanced NK Cell Therapy
How the Protocol Works
One guided flow from screening through post-visit continuity. Small cohorts. Limited annual capacity.
SNK01 · Japan Program
Baseline Mapping
We Assess Before We Approve
We assess goals, history, and eligibility before any approval decision. Licensed partner physicians determine suitability and risk alignment.
Clinic Visit in Japan
Structured, Supervised Care
Approved patients complete scheduled clinic steps with coordinated support. Structured monitoring and ongoing communication after your visit.
Small Cohorts. Limited Annual Capacity.
Request a structured consultation to review eligibility and clinical timing.
ⓘ Not approved by the FDA. SNK01 is under investigation and not authorized to diagnose, treat, cure, or prevent any disease in the United States.